The newly formed EASL International Liver Foundation is empowering an innovative program pursuing the dream of creating a ‘bioartificial liver’.
There are presently hundreds of thousands of people on the liver transplant waiting list, many of who will sadly die before finding a compatible donor. Even those fortunate enough to receive an organ in time face ongoing medical difficulties, often for the rest of their lives. But recent technical achievements in stem cell research, tissue engineering and whole organ regeneration and preservation offer potentially powerful solutions to this health crisis.
On May 2, the Foundation, in collaboration with Institut Pasteur, will host a first meeting bringing together world-leading experts in regenerative medicine to turn this revolutionary idea into a clinical reality.